Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vancomycin effects on gut microbiome and coagulation in lean and obese adults
NL-OMON20609Active, not recruiting
- Sponsor
- UiT The Arctic University of Norway
- Start
- May 2015
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of vancomycin (2 arms), sponsored by UiT The Arctic University of Norway. Primary endpoint: Factor VIII activity. Started May 2015; status: active, not recruiting.
02
Drugs
vancomycin
Beyond the preview
Go deeper on NL-OMON20609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20609.